.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 6,653,341

« Back to Dashboard

Details for Patent: 6,653,341

Title: Methods and compositions for use in treating cancer
Abstract:The invention provides methods and compositions for use in treating diseases associated with excessive cellular proliferation, such as cancer.
Inventor(s): Littlefield; Bruce A. (Andover, MA), Towle; Murray J. (Auburn, NH)
Assignee: Eisai Co., Ltd. (Tokyo, JP)
Filing Date:Oct 16, 2002
Application Number:10/272,167
Claims:1. A method of treating cancer in a patient, said method comprising administering to said patient a compound having the formula: ##STR4##

or a pharmaceutically acceptable salt thereof, in combination with a second approach to treatment.

2. The method of claim 1, wherein said second approach to treatment comprises administration of a chemotherapeutic drug to said patient.

3. The method of claim 2, wherein said chemotherapeutic drug is selected from the group consisting of antimetabolites, antibiotics, alkylating agents, plant alkaloids, and hormonal agents.

4. The method of claim 3, wherein said chemotherapeutic drug is an antimetabolite.

5. The method of claim 4, wherein said antimetabolite is gemcitabine.

6. The method of claim 5, wherein said cancer is non-small cell lung carcinoma, pancreatic cancer, or metastatic breast cancer.

7. The method of claim 4, wherein said antimetabolite is capecitabine.

8. The method of claim 7, wherein said cancer is breast cancer or colorectal cancer.

9. The method of claim 3, wherein said antibiotic is an anthracycline.

10. The method of claim 9, wherein said anthracycline is doxorubicin.

11. The method of claim 10, wherein said cancer is breast cancer.

12. The method of claim 3, wherein said chemotherapeutic drug is an alkylating agent.

13. The method of claim 12, wherein said alkylating agent is carboplatinum or cisplatinum.

14. The method of claim 13, wherein said cancer is non-small cell lung cancer or ovarian cancer.

15. The method of claim 3, wherein said chemotherapeutic drug is a plant alkaloid.

16. The method of claim 15, wherein said plant alkaloid is irinotecan.

17. The method of claim 16, wherein said cancer is colorectal cancer.

18. The method of claim 15, wherein said plant alkaloid is topotecan.

19. The method of claim 18, wherein said cancer is ovarian cancer or non-small cell lung cancer.

20. The method of claim 1, wherein said second approach to treatment comprises administration of an anticoagulant to said patient.

21. The method of claim 20, wherein said anticoagulant is heparin.

22. A composition comprising a compound having the formula: ##STR5##

or a pharmaceutically acceptable salt thereof, in combination with a second chemotherapeutic drug.

23. The composition of claim 22, wherein said chemotherapeutic drug is selected from the group consisting of antimetabolites, antibiotics, alkylating agents, plant alkaloids, and hormonal agents.

24. The composition of claim 23, wherein said chemotherapeutic drug is an antimetabolite.

25. The composition of claim 24, wherein said antimetabolite is gemcitabine.

26. The composition of claim 24, wherein said antimetabolite is capecitabine.

27. The composition of claim 23, wherein said antibiotic is an anthracycline.

28. The composition of claim 27, wherein said anthracycline is doxorubicin.

29. The composition of claim 23, wherein said chemotherapeutic drug is an alkylating agent.

30. The composition of claim 29, wherein said alkylating agent is carboplatinum or cisplatinum.

31. The composition of claim 23, wherein said chemotherapeutic drug is a plant alkaloid.

32. The composition of claim 31, wherein said plant alkaloid is irinotecan.

33. The composition of claim 31, wherein said plant alkaloid is topotecan.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc